MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 60 filers reported holding MEI PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,167 | -77.4% | 13,000 | -63.2% | 0.00% | – |
| Q3 2022 | $14,000 | -39.1% | 35,304 | -8.8% | 0.00% | – |
| Q2 2022 | $23,000 | -80.8% | 38,704 | -80.6% | 0.00% | – |
| Q1 2022 | $120,000 | -74.0% | 199,204 | +15.2% | 0.00% | -100.0% |
| Q4 2021 | $462,000 | -43.7% | 172,904 | -41.8% | 0.00% | -50.0% |
| Q3 2021 | $820,000 | -37.8% | 297,104 | -35.8% | 0.00% | -33.3% |
| Q2 2021 | $1,318,000 | -53.7% | 462,504 | -44.3% | 0.00% | -62.5% |
| Q1 2021 | $2,846,000 | +79.3% | 829,604 | +38.0% | 0.01% | +100.0% |
| Q4 2020 | $1,587,000 | +61.9% | 601,204 | +91.5% | 0.00% | +33.3% |
| Q3 2020 | $980,000 | +6.9% | 314,004 | +41.4% | 0.00% | 0.0% |
| Q2 2020 | $917,000 | +259.6% | 222,004 | +40.2% | 0.00% | +200.0% |
| Q1 2020 | $255,000 | +29.4% | 158,404 | +99.5% | 0.00% | – |
| Q4 2019 | $197,000 | +223.0% | 79,404 | +119.3% | 0.00% | – |
| Q3 2019 | $61,000 | -24.7% | 36,204 | +12.4% | 0.00% | – |
| Q2 2019 | $81,000 | +35.0% | 32,204 | +66.0% | 0.00% | – |
| Q1 2019 | $60,000 | +30.4% | 19,404 | +12.1% | 0.00% | – |
| Q4 2018 | $46,000 | – | 17,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|